EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 142 filers reported holding EPIZYME INC in Q4 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $62,000 | -50.8% | 24,686 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $126,000 | -38.5% | 24,686 | 0.0% | 0.01% | -40.0% |
| Q2 2021 | $205,000 | -4.7% | 24,686 | 0.0% | 0.02% | -31.0% |
| Q1 2021 | $215,000 | -19.8% | 24,686 | 0.0% | 0.03% | -72.4% |
| Q4 2020 | $268,000 | -9.2% | 24,686 | 0.0% | 0.10% | -3.7% |
| Q3 2020 | $295,000 | -25.5% | 24,686 | 0.0% | 0.11% | -36.3% |
| Q2 2020 | $396,000 | +173.1% | 24,686 | +75.1% | 0.17% | +185.0% |
| Q3 2019 | $145,000 | -59.0% | 14,098 | -50.0% | 0.06% | -9.1% |
| Q2 2019 | $354,000 | +326.5% | 28,196 | +442.6% | 0.07% | +120.0% |
| Q4 2015 | $83,000 | +23.9% | 5,196 | 0.0% | 0.03% | 0.0% |
| Q3 2015 | $67,000 | -46.4% | 5,196 | 0.0% | 0.03% | -47.4% |
| Q2 2015 | $125,000 | +27.6% | 5,196 | 0.0% | 0.06% | +1.8% |
| Q1 2015 | $98,000 | 0.0% | 5,196 | 0.0% | 0.06% | +7.7% |
| Q4 2014 | $98,000 | – | 5,196 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |